» Articles » PMID: 30854500

Development of a Fully Cross-Validated Bayesian Network Approach for Local Control Prediction in Lung Cancer

Overview
Publisher IEEE
Date 2019 Mar 12
PMID 30854500
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study is to demonstrate that a Bayesian network (BN) approach can explore hierarchical biophysical relationships that influence tumor response and predict tumor local control (LC) in non-small-cell lung cancer (NSCLC) patients before and during radiotherapy from a large-scale dataset. Our BN building approach has two steps. First, relevant biophysical predictors influencing LC before and during the treatment are selected through an extended Markov blanket (eMB) method. From this eMB process, the most robust BN structure for LC prediction was found via a wrapper-based approach. Sixty-eight patients with complete feature information were used to identify a full BN model for LC prediction before and during the treatment. Fifty more recent patients with some missing information were reserved for independent testing of the developed pre- and during-therapy BNs. A nested cross-validation (N-CV) was developed to evaluate the performance of the two-step BN approach. An ensemble BN model is generated from the N-CV sampling process to assess its similarity with the corresponding full BN model, and thus evaluate the sensitivity of our BN approach. Our results show that the proposed BN development approach is a stable and robust approach to identify hierarchical relationships among biophysical features for LC prediction. Furthermore, BN predictions can be improved by incorporating during treatment information.

Citing Articles

Prediction of early recurrence of adult-type diffuse gliomas following radiotherapy using multi-modal magnetic resonance images.

Salari E, Chen X, Wynne J, Qiu R, Roper J, Shu H Med Phys. 2024; 51(11):8638-8648.

PMID: 39221589 PMC: 11530302. DOI: 10.1002/mp.17382.


Predicting postoperative rehemorrhage in hypertensive intracerebral hemorrhage using noncontrast CT radiomics and clinical data with an interpretable machine learning approach.

Wang W, Dai J, Li J, Du X Sci Rep. 2024; 14(1):9717.

PMID: 38678066 PMC: 11055901. DOI: 10.1038/s41598-024-60463-2.


AI-Driven Models for Diagnosing and Predicting Outcomes in Lung Cancer: A Systematic Review and Meta-Analysis.

Kanan M, Alharbi H, Alotaibi N, Almasuood L, Aljoaid S, Alharbi T Cancers (Basel). 2024; 16(3).

PMID: 38339425 PMC: 10854661. DOI: 10.3390/cancers16030674.


Predictors on outcomes of cardiovascular disease of male patients in Malaysia using Bayesian network analysis.

Juhan N, Zubairi Y, Zuhdi A, Khalid Z BMJ Open. 2023; 13(11):e066748.

PMID: 37923353 PMC: 10626862. DOI: 10.1136/bmjopen-2022-066748.


Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration.

Wei L, Niraula D, Gates E, Fu J, Luo Y, Nyflot M Br J Radiol. 2023; 96(1150):20230211.

PMID: 37660402 PMC: 10546458. DOI: 10.1259/bjr.20230211.


References
1.
Chen M, Jiang G, Fu X, Wang L, Qian H, Zhao S . Prognostic factors for local control in non-small-cell lung cancer treated with definitive radiation therapy. Am J Clin Oncol. 2002; 25(1):76-80. DOI: 10.1097/00000421-200202000-00016. View

2.
Zlotnik A . Chemokines and cancer. Ernst Schering Res Found Workshop. 2004; (45):53-8. DOI: 10.1007/978-3-662-05403-1_4. View

3.
Aliferis C, Tsamardinos I, Statnikov A . HITON: a novel Markov Blanket algorithm for optimal variable selection. AMIA Annu Symp Proc. 2004; :21-5. PMC: 1480117. View

4.
Sachs K, Perez O, Peer D, Lauffenburger D, Nolan G . Causal protein-signaling networks derived from multiparameter single-cell data. Science. 2005; 308(5721):523-9. DOI: 10.1126/science.1105809. View

5.
ODonnell K, Wentzel E, Zeller K, Dang C, Mendell J . c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435(7043):839-43. DOI: 10.1038/nature03677. View